Jan 29, 2021 | Drug Development, News, Research news
What progress can patients and families expect to see in CMT research during 2021? What is the most promising research on the horizon? The CMT Research Foundation’s Chief Scientific Officer Keith Fargo, Ph.D., sat down with us to answer your most pressing questions...
Jan 11, 2021 | CMT Research Updates, News
As we begin 2021, I am overwhelmed with gratitude for your continued commitment to the CMT Research Foundation community. Despite a challenging last year, friends like you rose to the challenge and have made it possible for the CMT Research Foundation to fund new and...
Jan 11, 2021 | About CMT, CMT Research Updates, Drug Development, News, Research news
By: Susan Ruediger, CEO, CMT Research Foundation It costs more than $2.6 billion to develop an approved prescription medicine (Journal of Health Economics, 2016) and typically takes between 10 to 15 years to get a drug to clinical trials (Neuron, 2014). With no...
Dec 17, 2020 | CMT Research Updates, News, Research news
By: Susan Ruediger, CEO, CMT Research Foundation As we approach the end of 2020 and look ahead to a new year, it’s natural to feel hopeful about what the future may hold — hope for an end to the global pandemic; hope for happiness and good health for our families; and...